Search by Drug Name or NDC
NDC 68001-0245-00 Atovaquone and Proguanil Hydrochloride 250; 100 mg/1; mg/1 Details
Atovaquone and Proguanil Hydrochloride 250; 100 mg/1; mg/1
Atovaquone and Proguanil Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is ATOVAQUONE; PROGUANIL HYDROCHLORIDE.
MedlinePlus Drug Summary
The combination of atovaquone and proguanil is used to treat a certain kind of malaria infection (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) and to prevent a certain kind of malaria infection in travelers who visit areas where malaria is common. Atovaquone and proguanil is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
Related Packages: 68001-0245-00Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Atovaquone and Proguanil
Product Information
| NDC | 68001-0245 |
|---|---|
| Product ID | 68001-245_eff0fdfe-695c-4e62-e053-2a95a90ab50f |
| Associated GPIs | 13990002050320 |
| GCN Sequence Number | 045855 |
| GCN Sequence Number Description | atovaquone/proguanil HCl TABLET 250-100 MG ORAL |
| HIC3 | W4A |
| HIC3 Description | ANTIMALARIAL DRUGS |
| GCN | 89891 |
| HICL Sequence Number | 016487 |
| HICL Sequence Number Description | ATOVAQUONE/PROGUANIL HCL |
| Brand/Generic | Generic |
| Proprietary Name | Atovaquone and Proguanil Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Atovaquone and Proguanil Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 100 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| Labeler Name | BluePoint Laboratories |
| Pharmaceutical Class | Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091211 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68001-0245-00 (68001024500)
| NDC Package Code | 68001-245-00 |
|---|---|
| Billing NDC | 68001024500 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (68001-245-00) |
| Marketing Start Date | 2014-03-13 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.17822 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ATOVAQUONE-PROGUANIL 250-100 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis